WebSep 7, 2024 · Cann Group Limited ACN 603 949 739 4 Research Avenue, Bundoora, VIC 3083 Australia Ph: +61 3 9095 7088 ASX ANNOUNCEMENT 7 September 2024 Share Purchase Plan approved to proceed 7 September 2024 – Cann Group Limited (ASX: CAN) ( Cann or the Company ) announced today that, following shareholder approval … WebAug 29, 2024 · Cann Group Limited NWR Communications +61 (0) 3 9095 7088 +61 (0) 451 896 420 [email protected] [email protected] ... Cann Group Limited ABN 25 603 949 739 Reporting Period For the year ended: Previous corresponding period: Results for announcement to the market 2024 2016 Movement % …
Mildura facility licences granted - Cann Group Limited
WebAbout Cann Group. Cann Group Limited (ABN 25 603 949 739) is enhancing patients’ lives by developing, producing, and supplying innovative cannabis medicines. The Company has built world-class research, cultivation and GMP manufacturing facilities in Melbourne, and a state-of-the-art large-scale cultivation and GMP WebApr 6, 2024 · Cann Group Limited engages in the breeding, cultivation, production, manufacturing, clinical evaluation, and supplying medicinal cannabis for sale and use within Australia and for overseas export markets. About the company Risk Analysis Earnings have declined by 35.3% per year over past 5 years Has less than 1 year of cash runway biotech jobs in mass
Cann Group LinkedIn
WebCANN GROUP LIMITED (ACN# 603 949 739 A.C.N 603949739) is a Unlisted pubic company - Order a Credit Report from Information Brokers today to see the full credit … WebOct 11, 2024 · GIF. Cann Group. @Cann_Group. ·. Sep 1, 2024. We published our FY22 Annual Report earlier this week but, if you're pressed for time, you can also watch this short video update from our executive team about our commercial activities and what investors can expect for the year ahead. youtube.com. WebThis investor presentation (Presentation) has been prepared by Cann Group Limited (ABN 25 603 949 739) (Cann) and comprises written material regarding Cann. Summary information performance of daisy\\u0027s disputed merit inspires row